Stay updated with breaking news from Pharma Assay Development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
High-throughput, multi-omic single-cell Tapestri® VCN Assay quantifies vector copy number (VCN) and transduction in individual engineered cells in a single...
Board-certified pediatric oncologist brings vast experience in molecular diagnostics and building clinical programs to first-of-its-kind role at M...
Mission Bio Launches Pharma Assay Development Services to Speed Access to New Technologies New service reduces project time from months to weeks for biopharma customers News provided by Share this article SOUTH SAN FRANCISCO, Calif., April 20, 2021 /PRNewswire/ -- Mission Bio, the pioneer in high-throughput single-cell DNA and multi-omics analysis, today announced the launch of its Pharma Assay Development (PAD) services to accelerate biomarker discovery and cell and gene therapy development pipelines for biopharma customers. The PAD Team will provide customers with early access to services...